Literature DB >> 5553025

Intraocular toxocara.

C P Wilkinson, R B Welch.   

Abstract

Mesh:

Year:  1971        PMID: 5553025     DOI: 10.1016/0002-9394(71)90267-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  23 in total

Review 1.  An experimental approach to the study of intraocular Toxocara canis.

Authors:  M N Luxenberg
Journal:  Trans Am Ophthalmol Soc       Date:  1979

2.  The public health implications of urban dogs.

Authors:  A M Beck
Journal:  Am J Public Health       Date:  1975-12       Impact factor: 9.308

Review 3.  Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders?

Authors:  Chia-Kwung Fan; Celia V Holland; Karen Loxton; Ursula Barghouth
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

4.  Ocular toxocariasis in a patient with repeatedly negative ELISA titre to Toxocara canis.

Authors:  J A Sharkey; P S McKay
Journal:  Br J Ophthalmol       Date:  1993-04       Impact factor: 4.638

5.  Dominant exudative vitreoretinopathy and other vascular developmental disorders of the peripheral retina.

Authors:  C E van Nouhuys
Journal:  Doc Ophthalmol       Date:  1982-09-23       Impact factor: 2.379

6.  Prevalence of Toxocara canis in babies and in adults as determined by the ELISA test.

Authors:  J Berrocal
Journal:  Trans Am Ophthalmol Soc       Date:  1980

7.  Ocular toxocariasis in children and youth.

Authors:  H Zygulska-Mach; K Krukar-Baster; S Ziobrowski
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

8.  A syndromic approach to common parasitic diseases.

Authors:  S D Shafran; A W Chow
Journal:  CMAJ       Date:  1985-10-15       Impact factor: 8.262

9.  Visceral larva migrans (toxocariasis) in Toronto.

Authors:  M Fanning; A Hill; H M Langer; J S Keystone
Journal:  Can Med Assoc J       Date:  1981-01-01       Impact factor: 8.262

10.  Experimental ocular toxocariasis: a mouse model.

Authors:  S Y Ghafoor; H V Smith; W R Lee; R Quinn; R W Girdwood
Journal:  Br J Ophthalmol       Date:  1984-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.